Controlled chemical release of hydrogen sulfide
Agents of formula: where R1 and R2 vary independently and are acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, arylalkyl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocycle, or heteroatoms; and R3 is H or a member of a ring structure which includes R2, are provided; as are agents of formula: where R1, R2 and R3 vary independently and: R1=OH, OR′, NHR′, NR′R″ (with R′ R″=alkyl, aryl, heteroaryl, etc); R2=acyl, alkyl, aryl, sulfonyl, etc; R3=alkyl, aryl, substituted aryl, heteroaryl, etc; and R4 and R5 are (independently) H, methyl or alkyl, substituted alkyl, aryl, substituted aryl, etc. Methods of using the agents to treat e.g. cardiovascular disease, stroke, shock, injuries caused by hypoxia, male erectile dysfunction, and Alzheimer's are provided.
1. An agent for the controlled, sustained release of H 2 S having the chemical formula
where R1, R2 and R3 vary independently and: R1 is selected from the group consisting of OH, OR′, NHR′, and NR′R″ where R′ and R′ are selected from the group consisting of alkyl, aryl, and heteroaryl, R2 is selected from the group consisting of acyl, alkyl, aryl, and sulfonyl, R3 is selected from the group consisting of alkyl, aryl, substituted aryl, and heteroaryl, and R4 and R5 are independently selected from the group consisting of H, methyl or alkyl, substituted alkyl, aryl, and substituted aryl.
2. The agent of claim 1 , wherein said agent has the chemical formula
3. The agent of claim 1 , wherein said agent has the chemical formula